REGNRegeneron Pharmaceuticals, Inc.
NasdaqGS · Healthcare · Marktkap. $99.4B · Ø Volumen 733.95K
$961.26
+33.37 (+3.60%)
Erstanalyse
Regeneron Pharmaceuticals, Inc.
REGN
KaufenKostenloser Bericht · REGN
Setzen Sie REGN aufs Radar, bevor es die Masse tut.
Ein kostenloser Erstanalyse-Bericht — ohne Kosten, ohne Verpflichtung.
Schlüsseldaten
Letzter Kurs
$961.26
Tagesspanne
$927.00 - $974.00
Volumen
1.66M
G/V ($)
+$33.37
G/V (%)
+3.60%
Eröffnung
$927.22
Vortagesschluss
$927.89
52-Wochen-Spanne
$591.52 - $974.00
Marktkapitalisierung
$99.4B
Ausstehende Aktien
101.63M
Durchschnittsvolumen
733.95K
Rel. Volumen
2.3×
Kurs vom November 2, 2026, 7:14 PM ET
Nachrichten zu REGN
Oct 30, 2026, 12:14 PM - REGN: Regeneron Reports Q3 2026 Revenue of $10.46 Billion, Shares Surge 11%
REGN · StockWatch
REGN · StockWatch
REGN · Watch List News
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership. Institutional and Insider Ownership 83.3% of Regeneron Pharmaceuticals […]
REGN · Ticker Report
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Volatility & Risk Spyre Therapeutics has a beta […]
Listings an globalen Börsen
NASDAQ
US · USD
REGN
UX
NYSE
US · USD
REGN
US
OTC Bulletin Board
US · USD
REGN
UD
CBOE BZX
US · USD
REGN
UB
NASDAQ Capital Market
US · USD
REGN
UF
25 Börsen · aktualisiert am 29. Okt. 2026
Schlüsseldaten
Kennzahlen
Marktkapitalisierung
$99.4B
Ausstehende Aktien
101.63M
Streubesitz
96.32M
Beta
0.10
KGV
21.25
Gewinn je Aktie
$45.24
Rendite
0.41%
Dividende
$3.76
Ex-Dividenden-Datum
Nov 20, 2026
Leerverkaufsanteil
2.13M (Oct 15, 2026)
% des Streubesitzes leerverkauft
2.18%
Durchschnittsvolumen
733.95K
Rel. Volumen
2.3×
Kurs vom November 2, 2026, 7:14 PM ET